PL EN


Preferences help
enabled [disable] Abstract
Number of results
Journal
2012 | 10 | 5 | 1500-1505
Article title

Comparison of structure, logP and P388 cytotoxicity of some phenyl and ferrocenyl cyclic chalcone analogues. Application of RP-TLC for logP determination of the ferrocenyl analogues

Content
Title variants
Languages of publication
EN
Abstracts
EN
Cyclic chalcone analogues (2–5) and their ferrocenyl counterparts (6–10) were synthesized and their logP and P388 cyctotoxity were investigated. The structures of the newly synthesized compounds were confirmed by IR 1H and 13NMR spectroscopy. Comparison of conjugation and stereochemistry of the respective derivatives showed similar characteristics compared to ones with some higher degree of conjugation in the ferrocenyl series. Comparison of logP of the ferrocenyl derivatives determined by a validated RP-TLC method showed the ferrocenyl derivatives to have higher logP TLC. The results demonstrate that the differences in three dimensional shape, conjugation and lipophilicity do not have strong influence on the P388 cytotoxicity of the investigated phenyl (1−5) and ferrocenyl (6−10) enones. [...]
Publisher

Journal
Year
Volume
10
Issue
5
Pages
1500-1505
Physical description
Dates
published
1 - 10 - 2012
online
21 - 7 - 2012
Contributors
author
  • Institute of Pharmaceutical Chemistry, Semmelweis University, Budapest, 1092, Hungary
  • Institute of Pharmaceutical Chemistry, University of Pécs, Pécs, 7634, Hungary
author
  • Department of Chemistry, Eötvös Lóránd University (ELTE), and Protein Modelling Group ELTE-HAS, Budapest, 1117, Hungary, sohar@chem.elte.hu
author
  • Department of Chemistry, California State University Hayward, Hayward, CA, 94542, USA
author
  • Department of Pharmacology, University of Alberta, Edmonton, AB, T6G 2H7, Canada
References
  • [1] I. Kron, Z. Pudychová-Chovanová, B. Veliká, J. Guzy, P. Perjési, Monatsh. Chem. 143, 13 (2012) http://dx.doi.org/10.1007/s00706-011-0633-0[Crossref]
  • [2] V. Zsoldos-Mády, O. Ozohanics, A. Csámpai, V. Kudar, D. Frigyes, P. Sohár, J. Organomet. Chem. 694, 4185 (2009) http://dx.doi.org/10.1016/j.jorganchem.2009.09.007[Crossref]
  • [3] J.B. Harborne, In: V. Cody, E. Middleton Jr., E. Harborne (Eds.), Plant flavonoids in Biology and Medicine: Biochemical, pharmacological and structure-activity relationships (Alan R. Liss. Inc., New York, 1986) 15
  • [4] J.R. Dimmock, D.W. Elias, M.A. Beazely, N.M. Kandepu, Curr. Med. Chem. 6, 1125 (1999)
  • [5] M.L. Go, X. Wu, X.L. Liu, Curr. Med. Chem. 12, 483 (2005) http://dx.doi.org/10.2174/0929867053363153[Crossref]
  • [6] J.R. Dimmock, N.M. Kandepu, A.J. Nazarali, T.P. Kowalchuk, N. Motaganahalli, J.W. Quail, P. Mykytiuk, G.F. Audette, L. Prasad, P. Perjési, T.M. Allen, C.L. Santos, J. Szydlowski, E. De Clercq, J. Balzarini, J. Med. Chem. 42, 1358 (1999) http://dx.doi.org/10.1021/jm9806695[Crossref]
  • [7] J.R. Dimmock, G.A. Zello, E.O. Oloo, J.W. Quail, H-B. Kraatz, P. Perjési, K. Takács-Novák, F. Aradi, T.M. Allen, C.L. Santos, J. Balzarini, E. DeClerq, J.P. Stables, J. Med. Chem. 45, 3103 (2002) http://dx.doi.org/10.1021/jm010559p[Crossref]
  • [8] P. Perjési, U. Das, E. De Clercq, J. Balzarini, M. Kawase, H. Sakagami, J.P. Stables, T. Loránd, Zs. Rozmer, J.R. Dimmock, Eur. J. Med. Chem. 43, 839 (2008) http://dx.doi.org/10.1016/j.ejmech.2007.06.017[Crossref]
  • [9] A. Valkonen, K. Laihia, E. Kolehmainen, R. Kauppinen, P. Perjési, Struct. Chem. 23, 209 (2012) http://dx.doi.org/10.1007/s11224-011-9860-6[Crossref]
  • [10] P. Perjési, T. Nusser, Gy. Tarczay, P. Sohár, J. Mol. Struct. 479, 13 (1999) http://dx.doi.org/10.1016/S0022-2860(98)00805-9[Crossref]
  • [11] P. Perjési, Zs. Bayer, I. Ember, Anticancer Res. 20, 475 (2000)
  • [12] K. Monostory, V. Tamási, L. Vereczkey, P. Perjési, Toxicology 184, 203 (2003) http://dx.doi.org/10.1016/S0300-483X(02)00578-4[Crossref]
  • [13] Zs. Rozmer, T. Berki, P. Perjési, Toxicol. in Vitro 20, 1354 (2006) http://dx.doi.org/10.1016/j.tiv.2006.05.006[Crossref]
  • [14] P. Perjési, J. Kubalkova, Z. Chovanova, M. Marekova, Zs. Rozmer, K. Fodor, Z. Chavkova, V. Tomeckova, J. Guzy, Pharmazie 63, 899 (2008)
  • [15] C. Hansch, A. Leo, Substituent Constants for Correlation Analysis in Chemistry and Biology (John Wiley and Sons, New York, 1979)
  • [16] W.Y. Liu, T. Xie, Y.M. Liang, W.M. Liu, Y.X. Ma, J. Organometallic Chem. 627, 93 (2001) http://dx.doi.org/10.1016/S0022-328X(01)00717-3[Crossref]
  • [17] C. Biot, Curr. Med. Chem. - Anti-Infective Agents 3, 135 (2004) http://dx.doi.org/10.2174/1568012043354008[Crossref]
  • [18] S. Top, A. Vessières, C. Cabestaing, et al. J. Organometallic Chem. 500, 637 (2001)
  • [19] R. Kovjazin, T. Eldar, M. Patya, A. Vanichkin, H.M. Lander, A. Novogrodsky, FASEB J. 17, 467 (2003)
  • [20] E. Hillard, A. Vessieres, F. Le Bideau, D. Plazuk, D. Spera, M. Huche, G. Jaouen, Chem. Med. Chem. 1, 551 (2006)
  • [21] S.V. Lindeman, R.E. Bozak, R.J. Hicks, S. Husebye, Acta Chem. Scand. 51, 966 (1997) http://dx.doi.org/10.3891/acta.chem.scand.51-0966[Crossref]
  • [22] X. Wu, E. R.T. Tiekink, I. Kostetski, N. Kocherginsky, A. L.C. Tan, S. B. Khoo, P. Wilairat, M.-L. Go, Eur. J. Pharm. Sci. 27, 175 (2006) http://dx.doi.org/10.1016/j.ejps.2005.09.007[Crossref]
  • [23] M.S. Tute, Lipophilicity: A History. In: R. Mannhold, H. Kubiny, H. Timmerman (Eds.) Methods and Principles in Medicinal Chemistry, Vol. 4 - V. Pliska, B. Testa, H. van de Waterbeemd, Lipophilicity in Drug Action and Toxicology (VHC Publishers, Inc., Weinheim, FRG, 1996) 7–26
  • [24] K. Takács-Novák, P. Perjési, J. Vámos, JPC-J. Planar Chrom. 14, 42 (2001)
  • [25] P. Perjési, M. Takács, E. Ősz, Z. Pintér, J. Vámos, K. Takács-Novák, J. Chromatogr. Sci. 43, 289 (2005) [Crossref]
  • [26] Zs. Rozmer. P. Perjési, K. Takács-Novák, J. Planar Chrom. - Modern TLC 19, 124 (2006) http://dx.doi.org/10.1556/JPC.19.2006.2.7[Crossref]
  • [27] M.H. Abraham, N. Benjelloun-Dakhama, J.M.R. Gola, W.E. Jr. Acree, W.S. Cain, J.E. Cometto-Muniz, New J. Chem. 24, 825 (2000) http://dx.doi.org/10.1039/b004291i[Crossref]
  • [28] P. Sohár, P. Perjési, K.W. Törnroos, S. Husebye, A. Vértes, Gy. Vankó, R.E. Bozak, J. Mol. Struct. 524, 297 (2000) http://dx.doi.org/10.1016/S0022-2860(00)00380-X[Crossref]
  • [29] O.A. Phillips, L.A. Nelson, E.E. Knaus, T.M. Allen, R. Fathi-Afshar, Drug Des. Deliv. 4, 121 (1989)
  • [30] P. Perjési, A. Perjessy, E. Kolehmainen, E. Ősz, M. Samalikova, E. Virtanen, J. Mol Struct. 697, 41 (2004) http://dx.doi.org/10.1016/j.molstruc.2004.02.006[Crossref]
  • [31] P. Perjési, J. Linnanto, E. Kolehmainen, E. Ősz, E. Virtanen, J. Mol. Struct. 740, 81 (2005) http://dx.doi.org/10.1016/j.molstruc.2004.10.013[Crossref]
  • [32] A. Hoser, Z. Kaluski, H. Maluszynska, V.D. Orlov, Acta Crystallogr. B36, 1256 (1980) [Crossref]
  • [33] Z. Kaluski, E. Skrzypczak-Jankun, V.D. Orlov, I.A. Borovoi, Bull. Acad. Pol. Sci., Ser. Sci. Chim. 26, 869 (1978)
  • [34] P. Sohár, A. Csámpai, P. Perjési, Arkivok (V),114 (2003)
  • [35] A. Katrusiak, M. Ratajczak-Sitarz, Z. Kaluski, V.D. Orlov, Acta Crystallogr. C43, 103 (1987)
Document Type
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.-psjd-doi-10_2478_s11532-012-0088-0
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.